F · Healthcare
Drug Manufacturers - Specialty & Generic
H. LUNDBECK A/S SER.B DK1 (LDBA) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $5.14B, P/E ratio is 12.06, net margin is 13.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
H. LUNDBECK A/S SER.B DK1 (LDBA) has a reported market cap of $5.14B (data as of 2026-03-29).
The price-to-earnings (P/E) ratio for H. LUNDBECK A/S SER.B DK1 (LDBA) is 12.06 (data as of 2026-03-29).
Dividend yield is not available in the current snapshot for H. LUNDBECK A/S SER.B DK1 (LDBA). Check the MyAverix Finance app for the latest dividend data.
H. LUNDBECK A/S SER.B DK1 (LDBA) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
LDBA is listed on F.
H. LUNDBECK A/S SER.B DK1 (LDBA) reports a net margin of 13.0% (data as of 2026-03-29).
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.